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Abstract
Background: An arbitrary set of 96 human proteins was selected and tested to set-up a fully
automated protein production strategy, covering all steps from DNA preparation to protein
purification and analysis. The target proteins are encoded by functionally uncharacterized open
reading frames (ORF) identified by the German cDNA consortium. Fusion proteins were produced
in E. coli with four different fusion tags and tested in five different purification strategies depending
on the respective fusion tag. The automated strategy relies on standard liquid handling and clone
picking equipment.
Results: A robust automated strategy for the production of recombinant human proteins in E. coli
was established based on a set of four different protein expression vectors resulting in NusA/His,
MBP/His, GST and His-tagged proteins. The yield of soluble fusion protein was correlated with the
induction temperature and the respective fusion tag. NusA/His and MBP/His fusion proteins are
best expressed at low temperature (25°C), whereas the yield of soluble GST fusion proteins was
higher when protein expression was induced at elevated temperature. In contrast, the induction of
soluble His-tagged fusion proteins was independent of the temperature. Amylose was not found
useful for affinity-purification of MBP/His fusion proteins in a high-throughput setting, and metal
chelating chromatography is recommended instead.
Conclusion: Soluble fusion proteins can be produced in E. coli in sufficient qualities and µg/ml
culture quantities for downstream applications like microarray-based assays, and studies on
protein-protein interactions employing a fully automated protein expression and purification
strategy. Future applications might include the optimization of experimental conditions for the
large-scale production of soluble recombinant proteins from libraries of open reading frames.
Background
A number of cDNA projects [1-4] and ORF cloning
projects [5-9] currently provide comprehensive resources
for functional analysis in various organisms comprising
bacteria, plants, nematodes, as well as different mamma-
lian species. However, a considerable number of identi-
fied proteins still lacks functional annotation. Protein
microarrays present a promising tool among other
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approaches for the functional characterization of not yet
annotated proteins [10-14]. In the recent past, microarray-
based assays have been employed to identify novel pro-
tein-protein interactions, small molecule ligands, and
protein phosphorylation sites [15,16]. The production of
protein microarrays requires recombinant proteins in suf-
ficient quantities and of adequate purity, or their produc-
tion in situ [17]. In order to guarantee that proteins are
full-length and presented in a defined concentration on
the array, proteins must be produced ahead of the printing
process. The baculovirus as well as yeast expression sys-
tems have been exploited to produce proteins on a large
scale for subsequent production of microarrays [18]. Both
expression systems introduce host-specific post-transla-
tional modifications. In contrast, the bacterial expression
system Escherichia coli [19] produces proteins devoid of
those post-translational modifications typically present in
endogenously expressed mammalian proteins. This cir-
cumstance can be advantageous for certain applications,
e.g. to screen for novel substrates of human kinases. Fur-
thermore, E. coli is a well established expression system
with known growth kinetics, robust handling characteris-
tics, and high yields of recombinant proteins. Therefore,
we selected E. coli as expression system for the automated
production of uncharacterized human proteins from the
LIFEdb database [20]. Hence, the resulting in-vitro data
could help to bridge the knowledge from different large-
scale technologies for functional genomics and proteom-
ics applications [21,22].
Different automated strategies are commercially available
for bacterial high-throughput protein expression screen-
ing [23], or were established by different research groups
[24-29]. These approaches have several drawbacks in
common. For example, only a limited number of steps of
the workflow are automated, leaving the challenge to inte-
grate them into a fully automated system. The develop-
ment of an automated platform for bacterial protein
expression should also include DNA handling and quality
control steps, as well as the production, purification and
analysis of the recombinant proteins. Hence, we under-
took an independent approach based on commercial
robotics to set-up an improved platform for automated
protein expression screening. All individual steps, includ-
ing the preparation and characterization of expression
clones, transformation into bacteria, picking of expression
clones, growing bacterial cultures, induction of protein
expression, harvesting raw protein extracts, protein affin-
ity purification and subsequent quality control of purified
proteins (Figure 1, Table 1) were performed in a multi-
titer plate format and integrated in our protein production
strategy. In addition, quality control steps were also
included into the automated workflow. The correct insert
size of the expression clones was verified by agarose gel
electrophoresis, and the E-PAGE system (Invitrogen) was
Work flow of the automated protein production strategy Figure 1
Work flow of the automated protein production 
strategy. Automated steps are shown in orange, steps 
involving manual intervention are shown in blue.
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used to control the size and purity of affinity-purified pro-
teins. This resulted in the development of a robust proce-
dure which can easily be established on comparable clone
picking and liquid handling equipment.
Our integrated automated approach for the production of
recombinant human proteins [4,20] relies on the protein
expression vectors previously described [30]. Accordingly,
the four different expression vectors result in proteins N-
terminally tagged with Glutathione-S-transferase- (GST)
[31], hexahistidine- (His) [32], Maltose-binding protein-
(MBP)/hexahistidine-tag [32], or hexahistidine and E. coli
transcription-anti-termination-factor- (NusA) [33] (Table
2). In total, 96 Entry clones from the LIFEdb data base
[20] encoding uncharacterized human proteins were
selected for Gateway cloning [34] to yield expression
clones required for the induction of protein expression
[Additional file 1].
Results
Technical set-up of the fully automated system
The liquid handling steps required for ORF cloning, pro-
tein expression and protein purification were imple-
mented on the MULTI-probe II robot which was
controlled with the application system software, if possi-
ble. Additional external equipment integrated into the
robotic platform was navigated with the LabVIEW soft-
ware. Clone picking was realized on the QPix robot. Fig-
ure 1 summarizes the single steps implemented into the
automated routine. Open reading frames were transferred
by Gateway LR reaction into four different destination
vectors (Step1) and subsequently transformed into the
bacterial strain DH5α for the amplification of recom-
binant expression plasmids (Step2). The automated
restriction digest of expression plasmids confirmed the
correct insert size for 361 of the 384 expression clones
(Steps 3–5). Thus, 94% of destination clones were availa-
ble for transformation into the bacterial strain BL21-SI
(Step 6). In summary, each candidate was subjected to 15
different expression tests varying in the choice of fusion
tag, induction temperature and purification strategy, or a
combination thereof. Again, clone picking and the growth
of pre-cultures were performed using our automated set-
up (Steps 7, 8). However, the induction of protein expres-
sion by addition of IPTG or AHT is faster when performed
manually (Step 9). Cultures were placed on a shaker at the
indicated temperature (Step 10). Protein expression was
stopped by removing the culture medium using gravity-
driven filter plates. After lysis and affinity-purification
(Step 11) the yield of recombination fusion proteins was
analyzed using the E-PAGE system, a gel-based approach
suitable for the high throughput analysis of proteins (Step
Table 1: Overview on instrumentation and consumables
Robot Periphery Consumables
Gateway cloning MultiProbe II EX, PerkinElmer, 
Wellesley
VortexGenie 2, Scientific 
Industries, Bohemia
GeneAmp PCR System 9700, 
Applied Biosystems
Thermo-Fast 96 (ABgene, Epsom)
Transformation MultiProbe II EX, PerkinElmer, 
Wellesley
GeneAmp PCR System 9700, 
Applied Biosystems
Thermo-Fast 96 (ABgene, Epsom)
QTray, Vented (Genetix, New 
Milton)
Clone Picking QPix (Genetix, New Milton) 6.0 mL Storage Plate with 48 Wells 
(ABgene)
Plasmid purification MultiProbe II EX, PerkinElmer, 
Wellesley
Teleshake (H+P Labortechnik, 
München)
Vacuum Manifold for MultiScreen 
Plates (Millipore)
2.2 mL Storage Plate (ABgene)
Montage Plasmid Miniprep96 Kit 
(Millipore)
Restriction digest MultiProbe II EX, PerkinElmer, 
Wellesley
Thermo-Fast 96 (ABgene, Epsom)
Affinity purification MultiProbe II EX, PerkinElmer, 
Wellesley
ProtinoTrap M96/20 µm/L (M&N, 
Düren)
Table 2: Protein expression vectors [43]
Vector pQE80L-D33 pGST-1 pNusA pMBP
Backbone pQE-80L pGEX-6p-1 pASK75 pBAT4
Tag 1 His GST NusA MBP
Tag 2 none none His His
Promoter T5/lac tac tetR T7/lac
Induction IPTG IPTG AHT IPTGProteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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12). A single E-PAGE gel can accommodate all samples
from a 96-well plate and additional molecular weight
standards (Figure 2A, B). The final analysis is assisted by
the E-PAGE software allowing to reassemble twelve sam-
ple lanes, corresponding to a single 96-well row, into a
single image (Figure 2C). Calculation of the molecular
weight of the purified fusion proteins is based on a molec-
ular weight marker (Figure 2B, D). The yield is summa-
rized in the Additional file 1. In order to count as
successfully purified, the resulting fusion protein had to
yield a clean band of the expected molecular weight. This
analysis was performed using the E-PAGE system which
separates proteins over a distance of merely 2 cm. The low
resolution capacity of the E-PAGE system was accounted
for by introducing the rule that only those proteins were
regarded as successfully purified when at least two inde-
pendent expression tests resulted in a protein band of the
expected size. According to these criteria, 52% of the
uncharacterized proteins were purified in fusion with at
least one of the different tags, and quantities up to 10 µg/
ml culture were obtained (Additional file 1). This yield
was also reported for other strategies relying on the affin-
ity purification of fusion proteins from small volume cul-
tures [25,35]. However, the yield differs from our manual
approach, where close to 80% of fusion proteins were
obtained in quantities up to 100 µg/ml. Since the proteins
analyzed in these two studies were comparable with
respect to molecular weight and intracellular localization,
we conclude that parameters such as aeration of culture,
and the simplified one-step cell lysis and affinity purifica-
tion strategy contribute to the reduced overall yield of the
automated protein production strategy.
Influence of Fusion Tag and Temperature on Protein Yield
The influence of the different fusion tags was examined
(Figure 3) and compared with the outcome of our manual
approach. With respect to the impact of the induction
temperature on His-tagged protein expression, 15% (14
proteins), 19% (18 proteins), 5% (5 proteins) of His-tag
proteins were purified when induced at a temperature of
25°C, 30°C, and 37°C, respectively. For reasons of tech-
nical simplicity, a one-step lysis and purification proce-
dure was performed in the automated approach. This one-
step procedure monitored exclusively the successfully
purified proteins without analyzing the percentage of
inducible proteins. Moreover, with an average yield of
close to 30%, His-tagged fusion proteins were slightly bet-
ter soluble when protein expression was induced in the
manual approach [30].
We could confirm for the automated approach that the
NusA tag potentially increases the solubility of difficult to
express proteins. The expression of NusA-fusion proteins
is more efficient at lower temperature [30]. For example,
42 (44%) NusA-fusion proteins could be purified when
protein expression was induced at 25°C, but only 24
(25%) and 5 (5%) of NusA fusion proteins were purified
when protein expression was induced at 30°C and 37°C,
respectively. Quite the reverse was found for GST fusion
proteins which were produced more efficiently when pro-
Quality control of recombinant fusion proteins Figure 2
Quality control of recombinant fusion proteins. (A) Image of a Coomassie-stained E-PAGE gel, here shown for the puri-
fication of GST fusion proteins. (B) 96 samples can be loaded on a single E-PAGE gel comprising twelve lanes in eight rows (A-
H). A single additional lane is available per row to accommodate a molecular weight standard. (C) Single lanes (each 2 cm in 
length) are assembled to an artificial gel image to facilitate sample analysis. (D) Example molecular weight marker separated by 
the E-PAGE system.Proteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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tein expression was induced at elevated temperature. In
our automated approach, 26 GST-fusion proteins (27%)
were successfully purified when protein expression was
induced at 37°C, 18 (19%) at 25°C, and 16 (17%) at
20°C. The MBP-tag behaved comparably to the NusA-tag,
the number of successfully purified proteins decreased
with increasing induction temperature (17, 15, and 2 pro-
teins with increasing induction temperature).
Furthermore, we could confirm that amylose-based affin-
ity chromatography does not perform well in an auto-
mated setting previously reported by Braun et al. [25]. In
detail, MBP/His-fusion protein purified by metal chelate
chromatography resulted in 36 soluble fusion proteins
(38%) whereas merely 19% of MBP/His fusion tag pro-
teins were obtained after amylose-based affinity chroma-
tography (Table 3).
Discussion
Development of the automated process
A comprehensive automation of working steps including
transformation, bacterial culture, cell disruption and pro-
tein extraction, as well as protein purification, and quality
control of the purified proteins has been developed to
provide material for the large-scale in vitro characteriza-
tion of human proteins. Every single step (Figure 1) con-
tributed its own particular challenge which had to be
solved to fit into a comprehensive automated protein
expression approach.
Bacteria can efficiently be transformed by electroporation
on a single-clone basis. However, this procedure is diffi-
cult to automate and to parallelize, and technical limita-
tions exclude its application in a multi-well format.
Therefore the transformation of bacteria by heat shock
was chosen, which can proficiently be realized by integrat-
ing a PCR machine or a thermoblock on the robot desk.
The vessel dimensions, such as fermenter, Erlenmeyer
flask, tube and deep well block, as well as well shape, size
and volume and the shaking frequency influence the gas-
liquid mass transfer characteristics. Gas-liquid mass trans-
fer phenomena in microtiter plates were described by Her-
mann et al. [36], and therefore 48-well blocks instead of
96-well blocks were chosen to insure sufficient aeration of
the cultures. When we compared bacterial growth rates in
48-well plates with differently shaped wells, we observed
that the cultures grew at a higher rate when square-shaped
flat bottom wells were employed instead of wells with a
round well U-bottom. This reflects most likely the more
vigorous mixing of liquids in square-shaped wells. In the
automated set-up presented here, bacterial cell lysis and
affinity chromatography were performed as a one-step
procedure without relying on sonication to break up cell
walls. Insoluble material was not separated from the
slurry due to difficulties to implement this step in our
automated platform. Consequently, this automated strat-
Influence of fusion tag and induction temperature on fusion  protein yield Figure 3
Influence of fusion tag and induction temperature on 
fusion protein yield. Successfully purified human fusion 
proteins sorted according to fusion tag and purification strat-
egy. Protein expression was induced at 25°C (white), 30°C 
(dark grey) and 37°C (light grey), respectively.
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Table 3: Yield of soluble recombinant protein. Results sorted according to ORF size [kDa].
ORF size [kDa] ORF count [n] purif. ORF [n] Yield ORF [%] Hisa Hisb NusAa Hisb GSTa GSTb MBPa MBPb MBPa Hisb
0–9 2 1 50 1 0 0 0 1
10–19 1 0 9 9 04 88 57
20–29 21 15 70 6 11 8 6 14
30–39 15 10 70 2 8 4 3 6
40–49 15 10 70 3 10 6 4 7
50–59 3 1 30 0 1 0 0 0
60–69 8 3 40 2 1 0 0 0
70–79 5 2 40 1 1 0 0 0
80–89 7 2 30 0 2 0 0 1
90–99 6 0 0 0 00 00
≥ 100 4 0 0 0 00 00
a fusion tag
b tag employed for purification strategyProteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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egy does not deliver information regarding the induction
of insoluble fusion proteins.
Influence of fusion tag and induction temperature on 
protein induction
Hydrophilic fusion tags such as NusA, MBP and GST
enhance fusion protein solubility [33] when fused N-ter-
minally to the ORF. This has previously been tested in
large-scale protein expression strategies [25,30]. In the
case of NusA and MBP fusion tags, protein expression at
low temperatures yielded a higher percentage of soluble
recombinant proteins. According to results from our auto-
mated approach, this finding applies exclusively to pro-
teins induced at a low level (i.e. ORFs no. 3, 6, 96). In
contrast, proteins inducible with a high yield were found
to remain soluble over a broad temperature range (i.e.
ORF no. 13, 18, 22, 26, 41, 79).
The MBP-tag is known to support proper folding of
recombinant proteins and to enhance protein solubility
[37,38]. The affinity of MBP to amylose can be exploited
for affinity purification. Nevertheless, the binding of MBP
to amylose is too inefficient to be useful in a high-
throughput setting, and a high proportion of MBP fusion
proteins were observed in the flow through and wash frac-
tions, resulting in a low overall yield. Thus, purifying
MBP-fusion proteins via their internal His-tag on metal
chelating chromatography turned out to be the better
choice. With respect to difficult-to-express proteins such
as membrane proteins, the NusA tag is useful as long as
the induction of protein expression is performed at 20–
25°C, and with sufficient aeration [30].
Characterization of fusion proteins
Occasionally, translation of GST- and MBP-tag fusion pro-
teins stopped prematurely and the fusion tag itself co-
purified with the fusion protein. This effect was even more
pronounced for the NusA-tag. In summary, controlling
quality and purity of purified recombinant proteins by
SDS-PAGE, for example by using the E-PAGE system, is
mandatory as efficient quality control.
Comparison with other approaches
Bussow and coworkers have described the heterologous
high-throughput production of 10,825 human clones in
E. coli. In this case, 1,866 proteins purified as hexahisti-
dine-tagged soluble protein of at least 15 kDa (17%) [39].
A comparable success rate, 16 % of soluble His-tagged
proteins, was obtained in this approach with respect to
the automated purification of His-tagged fusion proteins.
However, in contrast to their approach, the vacuum-filter
plate was replaced with a gravity-filter plate in our set-up,
thus reducing extensive foaming that we observed in fil-
tration steps after applying a strong vacuum. Extensive
foam formation can easily result in well-to-well cross con-
tamination.
Braun et al. [25] tested the automated purification of 32
different human proteins sizing between 16–220 kDa
using four different fusion tags, among them MBP, GST
and the hexahistidine tag. According to their results, sixty
percent of the proteins were purified under non denatur-
ing conditions. MBP and GST fusion tag proteins resulted
in better yields than fusion proteins with a short tag, such
as the hexahistidine tag. They also reported that the affin-
ity of MBP to amylose as too low to be employed in a high
throughput strategy. In contrast, 21% of GST fusion pro-
teins and 11% of MBP fusion protein were purified, when
expression tests performed at the three different tempera-
tures were taken into account. However, Braun et al. tested
protein expression exclusively at 25°C, and the apparent
discrepancy between their results and our results can be
explained with the temperature dependence of GST fusion
protein expression. In our high-throughput set-up, the
best yield was obtained when GST fusion proteins were
induced at 37°C. Moreover, when our 37°C data were
omitted from the comparison, success rates for our data
set and for the Braun study were comparable. Pryor and
Leiting tested the efficiency of the GST tag and the MBP tag
for the production of soluble recombinant protein on a
small scale at two different induction temperatures, 18°C
and 37°C, and reported the MBP tag as superior at both
temperatures [40]. This result contrasts our experience
with the MBP fusion tag, but might be explained with by
the very limited number of only two proteins tested by
Pryor and Leiting.
Moreover, Braun et al. [25] observed that the yield of
recombinant proteins also strongly depends on the sub-
cellular localization of the endogenous protein. Integral
membrane proteins and secreted proteins requiring sepa-
rate optimization and purification methods and were
therefore excluded from their study. As much as 50% of
the total proteins encoded in the human genome are sup-
posedly membrane or secreted proteins, and a unique
strategy would be useful to purify also this large fraction
of proteins. In contrast to Braun et al. [25], the strategy
presented here did not exclude difficult to express pro-
teins. We previously reported that the NusA tag is benefi-
cial for the expression of difficult proteins which was
confirmed in other non high throughput settings [24].
However, Hammarström et al. [41] compared the benefits
of seven different fusion tags for the production of recom-
binant proteins in E. coli, and MBP was reported to be
superior over NusA as fusion tag. In this instance, only
small proteins (< 20 kDa) were tested, and protein expres-
sion was induced at 37°C. Again, the strong temperature
dependence of both tags and the fact that only small pro-Proteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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teins had been selected certainly contribute to the
observed differences.
Conclusion
The automated protein production approach presented
here introduces a simplified one-step lysis and purifica-
tion procedure for affinity purification of soluble mam-
malian proteins. According to our data, NusA fusion
proteins should be induced at a low temperature (25°C),
whereas GST fusion proteins are better induced at elevated
temperature. The purification of fusion protein should be
based on metal chelating chromatography, or on affinity
to Glutathione. Our strategy can ideally be applied as
screening routine for the identification of highly soluble
proteins which are required in structural analysis. The
selected target proteins can subsequently be produced on
a larger scale using a manual approach. In addition, our
automated strategy is also useful, when large numbers of
different fusion proteins are required, but µg-quantities of
purified proteins are sufficient. This applies to high-
throughput approaches as realized in functional assays
performed in the protein microarray format, or on arrays
with compound libraries. In summary, a robust robotic
set-up based on standard instrumentation is described
which overcomes inefficient steps from other strategies by
introducing optimized automated steps, and comprises a
larger number of automated steps than before described.
This set-up can easily be established on comparable liq-
uid-handling robotics.
Methods
Automated cloning, purification and characterization of 
Gateway-expression clones
The Gateway Cloning system (Invitrogen, Karlsruhe, Ger-
many) was used to generate the protein expression clones
listed in the Additional file 1[34]. Open reading frames
were available as entry clones without their native stop
codons in vector pDONR201 [42]. Consequently, all
fusion proteins contain C-terminally additional amino
acids encoded by the respective destination plasmids [30].
All steps to clone the human ORFs [4,20]; e.g. LR-reaction,
transformation into bacteria, plasmid purification, nor-
malization of DNA concentration, were automated and
carried out in a 96-well format. Pipetting was performed
on a Perkin Elmer Multiprobe II robot. The LR-reaction
was performed in a volume of 15 µl; 3 µL LR reaction
buffer (5×), 150 ng expression vector (5 µL) and 2 µL LR
CLONASE enzyme mix were pipetted into each well.
Finally 5 µL (20 ng/µL) of entry clone DNA were added.
Mixing was performed by shaking (Variomag Teleshake,
H+P Labortechnik). The plate was transferred on to an
integrated PCR machine (Applied Biosystems, Geneamp
PCR System 9700), and incubated at 16°C over night. The
reaction was stopped by addition of 5 µL Proteinase K
(Invitrogen). Next, 50 µL of competent DH5α cells were
pipetted into each well of a chilled 96-well plate. 5 µL LR-
reaction were added to each of the wells. For heat shock
transformation, the plate was placed manually on to a
PCR machine, and the samples were incubated at 42°C
for 45 s, then the temperature adjusted to 0°C and incu-
bation continued for another 5 min. Finally 500 µL of pre-
warmed LB medium were added, and the plate was placed
for 1 h onto an orbital shaker (Infors) at 37°C. A suspen-
sion with transformed bacteria (100 µL) was pipetted
from each well to a corresponding well of a 48-well agar
plate (Genetix, New Milton, UK), containing 3–5 glass
beads of 3 mm diameter (Roth). A homogenous distribu-
tion of the suspension was achieved by gentle shaking.
Bacteria were grown over night at 37°C. Single clones
were picked using the QPix robot (Genetics). Plasmids
were prepared from single colonies using commercial kits
(Montage 96, Plasmid MiniprepKit, Millipore), with the
protocol adapted to a Perkin Elmer Multiprobe robot.
Expression clones were confirmed by robotically per-
formed restriction digestion with BsrG1, cleaving the
Gateway recombination sites, and electrophoresis in 96
lane agarose gels (1% agarose in TAE buffer). The concen-
tration of DNA was estimated by a 260/280 measurement
in Costar UV Plates (Corning Lifesciences, Acton) on a
SpectraMax190 (Molecular Devices, Sunnyvale).
Automated induction of protein expression
The heat shock transformation was performed using 50 ng
of the expression plasmid added to 50 µL  E. coli
BL21(DE3) cells (Invitrogen). Target proteins were
expressed in duplicate on a 4 mL scale in deep well blocks
(Greiner).
Precultures were inoculated with a single colony and from
a 48-well agar plate (Genetix QPix), and grown in 48 well
blocks (Greiner) in 1 mL LB medium. After incubation for
16 h at 30°C, aliquots of 100 µL preculture were used to
inoculate 3.6 mL prewarmed LB medium in the 48-deep
well format. Two 48-well blocks were processed at a time
at 25°C, 30°C, or 37°C. Recombinant protein expression
was induced after 1.5 h, 2 h, and 3.5 h, depending on the
expression temperature, by adding either 1 mM IPTG or
0.43 mM AHT (see Table 4 for details). Bacteria were har-
vested after 12 h continued culture by centrifugation for
10 min at 2,500 × g. Medium was removed by aspiration,
and the remaining pellets were kept at -20°C for further
analysis.
The E-PAGE system of Invitrogen was utilized for protein
expression analysis, where a single gel can be loaded with
96 samples. All samples from one induction were loaded
on a single E-PAGE gel with the pipetting robot. Electro-
phoresis was controlled by the standard soft- and hard-
ware of the robot (Multiprobe, Perkin Elmer).Proteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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Automated protein purification and characterization of 
fusion proteins
Deep well blocks containing the frozen E. coli pellets were
placed on a Variomag shaker that had been mounted on
the operation deck of the Multiprobe II robot, and shaker
movement was controlled through the LabVIEW software.
The cell pellets were thawed on ice and resuspended in
500 µL resuspension buffer (see Table 4 for details, one
tablet EDTA-free protease inhibitor (Roche) was added to
50 mL buffer). A 50 µL buffer aliquot containing 0.3
units/µL Benzonase (Merck), 2.6 µg/µL Lysozyme
(Sigma), and 6.5 mM PMSF (Roth) was added. After mix-
ing briefly, 100 µL of a 50 % slurry affinity resin were
pipetted to each well, and incubated for 20 min at RT with
shaking adjusted to 500 rpm. The slurry was transferred to
a 20 µm gravity-driven filter plate (M96/20 µm/I, MACH-
EREY-NAGEL), and placed on a vacuum chamber (QIA-
GEN). The filtration was supported by a slight vacuum of
50 mbar for 20 s. The resin was washed three times with
450 µL of the appropriate buffer (Table 4) also supported
by a slight vacuum. Finally, a microtiter plate was placed
in the vacuum chamber and the target proteins were
eluted in three steps using 80 µL elution buffer.
Automated analysis of the purified fusion proteins
20 µL eluate were mixed with sample buffer and analyzed
(E-PAGE system). 96 samples and appropriate markers
were loaded and analyzed per gel. Gels were run at 500 V
for 10 min, stained with 0.1% Coomassie R250,
destained, and scanned for evaluation and documenta-
tion (Diana II Imaging System, raytest). The gels were ana-
lyzed manually and the resulting information was stored
in an internal data base.
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Table 4: Buffers and materials used for protein purification
His-Tag GST-Tag MBP-Tag
Resin Ni-NTA Superflow (QIAGEN) Glutathione Sepharose 4B (Amersham 
Biosciences)
Amylose resin (New England Biolabs)
Resuspension/
extraction
50 mM NaH2PO4, pH 8 300 mM NaCl 
10 mM imidazole adjust pH w/NaOH
20 mM Tris-HCl, pH 8 500 mM NaCl 1 
mM EDTA 1 mM DTT
20 mM Tris-HCl, pH 7.4 200 mM NaCl 
1 mM EDTA
Wash 50 mM NaH2PO4, pH 8 300 mM NaCl 
20 mM imidazole adjust pH w/NaOH
PBS, pH 7.3 20 mM Tris-HCl, pH 7.4 200 mM NaCl 
1 mM EDTA
Elution 50 mM NaH2PO4, pH 8 300 mM NaCl 
250 mM imidazole adjust pH w/NaOH
PBS 20 mM glutathione (red.) Wash buffer 10 mM maltoseProteome Science 2008, 6:4 http://www.proteomesci.com/content/6/1/4
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